The COVID-19 pandemic should not jeopardize dengue control.
Marie-Marie OliveThierry BaldetJames DevillersJohanna FiteMarie-Claire PatyChristophe PaupyPhilippe QuénelElsa QuilleryJocelyn RaudeJean-Paul StahlMarie Thiann-Bo-MorelDavid RoizPublished in: PLoS neglected tropical diseases (2020)
The concurrent circulation of dengue and coronavirus disease 2019 (COVID-19) may produce many unfavourable outcomes-such as co-infections; delays in diagnosis, treatment, and mitigation measures; overwhelming of the healthcare system; underreporting of cases; deterioration in surveillance and control interventions; and exacerbation of social inequalities. Indeed, lockdown is greatly compromising the effectiveness of vector control, especially social mobilization campaigns and preventive insecticide spraying in private spaces (indoor and peridomestic spraying). Thus, failure to appropriately implement the full range of vector control interventions can lead to a reduction in their overall effectiveness and an increasing risk of vector-borne diseases circulating. Consequently, the health community and policy makers should develop proactive policies and allocate adequate resources to prevent and manage the resurgence of dengue and other vector-borne diseases in the new era of COVID-19.
Keyphrases
- coronavirus disease
- healthcare
- public health
- mental health
- aedes aegypti
- zika virus
- sars cov
- dengue virus
- randomized controlled trial
- physical activity
- systematic review
- chronic obstructive pulmonary disease
- respiratory syndrome coronavirus
- particulate matter
- adipose tissue
- skeletal muscle
- risk assessment
- insulin resistance
- health information
- intensive care unit
- health insurance
- locally advanced
- social media
- extracorporeal membrane oxygenation
- weight loss
- drinking water
- combination therapy